Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard, +15

Journal of Clinical Oncology

Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer

Ivo A. Olivotto, Chris Bajdik, Peter M. Ravdin, +6

Journal of Clinical Oncology

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

Stephen Chia, B. Norris, Caroline Speers, +7

Journal of Clinical Oncology

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163

Susan Ellard, Mark Clemons, Karen A. Gelmon, +14

Journal of Clinical Oncology

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand, +7

Cancer

Eighty-seven PatientsPancreatic CancerGastrointestinal OncologyMedicinePharmacology +10

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.

M E Trudeau, Elizabeth A. Eisenhauer, B P Higgins, +6

Journal of Clinical Oncology

Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8

B. Norris, Kathleen I. Pritchard, K. James, +13

Journal of Clinical Oncology

National Cancer InstituteMetastatic Breast CancerOncologyBreast OncologyMedicine +13

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen

Hagen F. Kennecke, Ivo A. Olivotto, Caroline Speers, +4

Annals of Oncology

Late RiskBreast OncologyEarly Breast CancerMedicineGynecology +8

Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.

D Perrault, E. Eisenhauer, K. I. Pritchard, +4

Journal of Clinical Oncology

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.

Kathleen I. Pritchard, Alexander Paterson, Shai Fine, +19

Journal of Clinical Oncology